Steven Curran

Steven Curran serves as a key procurement professional within the Science and Technology Acquisition Division of the Department of Homeland Security’s Office of Procurement Operations, where he leads the acquisition of advanced scientific and engineering capabilities critical to national security. He specializes in managing complex research and development contracts focused on biotechnology, life sciences, and next-generation detection systems, ensuring the timely delivery of innovative solutions to enhance homeland defense infrastructure, cybersecurity, and biothreat mitigation. His work directly supports the division’s mission to bridge cutting-edge scientific discovery with operational readiness across federal agencies. Curran maintains a primary contracting relationship with Microsoft Corporation, leveraging its enterprise-scale R&D infrastructure and cloud-based analytical platforms to support large-scale scientific modeling, data integration, and secure computational environments. His procurement approach emphasizes long-term strategic partnerships with industry leaders capable of delivering scalable, interoperable technologies under strict federal compliance frameworks, including FedRAMP and NIST standards. He prioritizes vendors with proven capabilities in high-assurance systems and agile development methodologies. Curran’s procurement portfolio reflects a strict focus on full and open competition, with 100% of awards issued under no set-aside conditions. This underscores a deliberate strategy to prioritize technical excellence and mission-critical performance over socioeconomic preferences, ensuring access to the broadest possible pool of qualified, high-capability vendors capable of meeting the division’s demanding technical requirements. His primary procurement focus is on NAICS 541714—Research and Development in Biotechnology—where he acquires advanced biosensors, genomic analysis tools, pathogen detection platforms, and bioinformatics systems. He specializes in procuring proprietary research technologies, laboratory automation, and secure data analytics solutions that enable rapid threat identification and response, positioning him at the forefront of biodefense innovation within federal acquisition.